Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.09205
-0.0180 (-16.32%)
Jul 9, 2026, 4:00 PM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $7.14 million as of July 10, 2026.
Market Cap
7.14M
Enterprise Value
7.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since July 27, 2021, Biomind Labs's market cap has decreased from 18.69M to 7.14M, a decrease of -61.80%. That is a compound annual growth rate of -17.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.14M | -19.25% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | 18.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 13.64M |
| Brainstorm Cell Therapeutics | 13.61M |
| Nymox Pharmaceutical | 12.24M |
| LianBio | 11.96M |
| Adaptimmune Therapeutics | 10.34M |
| Synlogic | 8.20M |
| Reviva Pharmaceuticals Holdings | 7.87M |
| NKGen Biotech | 7.84M |